
### [MONDO:0015885](http://purl.obolibrary.org/obo/MONDO_0015885)
**Label:** rare insulin-resistance syndrome

**Subclasses:** [MONDO:0014686](http://purl.obolibrary.org/obo/MONDO_0014686) (short stature, microcephaly, and endocrine dysfunction), [MONDO:0012520](http://purl.obolibrary.org/obo/MONDO_0012520) (insulin-resistance syndrome type A), [MONDO:0019017](http://purl.obolibrary.org/obo/MONDO_0019017) (short fifth metacarpals-insulin resistance syndrome), [MONDO:0010020](http://purl.obolibrary.org/obo/MONDO_0010020) (congenital generalized lipodystrophy type 2), [MONDO:0016464](http://purl.obolibrary.org/obo/MONDO_0016464) (insulin-resistance syndrome type b), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0014991](http://purl.obolibrary.org/obo/MONDO_0014991) (Seckel syndrome 10; SCKL10), [MONDO:0018575](http://purl.obolibrary.org/obo/MONDO_0018575) (microcephalic primordial dwarfism-insulin resistance syndrome), [MONDO:0008696](http://purl.obolibrary.org/obo/MONDO_0008696) (acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome), [MONDO:0009874](http://purl.obolibrary.org/obo/MONDO_0009874) (Rabson-Mendenhall syndrome), [MONDO:0018573](http://purl.obolibrary.org/obo/MONDO_0018573) (intrauterine growth restriction-short stature-early adult-onset diabetes syndrome), [MONDO:0017230](http://purl.obolibrary.org/obo/MONDO_0017230) (autosomal semi-dominant severe lipodystrophic laminopathy), [MONDO:0012071](http://purl.obolibrary.org/obo/MONDO_0012071) (congenital generalized lipodystrophy type 1), [MONDO:0019193](http://purl.obolibrary.org/obo/MONDO_0019193) (acquired generalized lipodystrophy), [MONDO:0009517](http://purl.obolibrary.org/obo/MONDO_0009517) (Donohue syndrome), [MONDO:0010026](http://purl.obolibrary.org/obo/MONDO_0010026) (short syndrome), [MONDO:0015308](http://purl.obolibrary.org/obo/MONDO_0015308) (laminopathy type Decaudain-Vigouroux), [MONDO:0013225](http://purl.obolibrary.org/obo/MONDO_0013225) (congenital generalized lipodystrophy type 4), [MONDO:0013478](http://purl.obolibrary.org/obo/MONDO_0013478) (PLIN1-related familial partial lipodystrophy), [MONDO:0012923](http://purl.obolibrary.org/obo/MONDO_0012923) (congenital generalized lipodystrophy type 3), 

**Mapped go classes:** [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0016925](http://purl.obolibrary.org/obo/GO_0016925) (protein sumoylation), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0042134](http://purl.obolibrary.org/obo/GO_0042134) (rRNA primary transcript binding), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0003841](http://purl.obolibrary.org/obo/GO_0003841) (1-acylglycerol-3-phosphate O-acyltransferase activity), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0048884](http://purl.obolibrary.org/obo/GO_0048884) (neuromast development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0016411](http://purl.obolibrary.org/obo/GO_0016411) (acylglycerol O-acyltransferase activity), [GO:0034184](http://purl.obolibrary.org/obo/GO_0034184) (positive regulation of maintenance of mitotic sister chromatid cohesion), [GO:0070836](http://purl.obolibrary.org/obo/GO_0070836) (caveola assembly), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0046474](http://purl.obolibrary.org/obo/GO_0046474) (glycerophospholipid biosynthetic process), [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen), [GO:0050688](http://purl.obolibrary.org/obo/GO_0050688) (regulation of defense response to virus), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0006303](http://purl.obolibrary.org/obo/GO_0006303) (double-strand break repair via nonhomologous end joining), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0009303](http://purl.obolibrary.org/obo/GO_0009303) (rRNA transcription), [GO:0000722](http://purl.obolibrary.org/obo/GO_0000722) (telomere maintenance via recombination), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0030915](http://purl.obolibrary.org/obo/GO_0030915) (Smc5-Smc6 complex), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0001819](http://purl.obolibrary.org/obo/GO_0001819) (positive regulation of cytokine production), [GO:2000147](http://purl.obolibrary.org/obo/GO_2000147) (positive regulation of cell motility), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0006361](http://purl.obolibrary.org/obo/GO_0006361) (transcription initiation from RNA polymerase I promoter), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0045842](http://purl.obolibrary.org/obo/GO_0045842) (positive regulation of mitotic metaphase/anaphase transition), [GO:0006363](http://purl.obolibrary.org/obo/GO_0006363) (termination of RNA polymerase I transcription), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0046935](http://purl.obolibrary.org/obo/GO_0046935) (1-phosphatidylinositol-3-kinase regulator activity), [GO:1990683](http://purl.obolibrary.org/obo/GO_1990683) (DNA double-strand break attachment to nuclear envelope), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:0019843](http://purl.obolibrary.org/obo/GO_0019843) (rRNA binding), [GO:0050995](http://purl.obolibrary.org/obo/GO_0050995) (negative regulation of lipid catabolic process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0060036](http://purl.obolibrary.org/obo/GO_0060036) (notochord cell vacuolation), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0043551](http://purl.obolibrary.org/obo/GO_0043551) (regulation of phosphatidylinositol 3-kinase activity), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0006654](http://purl.obolibrary.org/obo/GO_0006654) (phosphatidic acid biosynthetic process), [GO:0008307](http://purl.obolibrary.org/obo/GO_0008307) (structural constituent of muscle), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0030299](http://purl.obolibrary.org/obo/GO_0030299) (intestinal cholesterol absorption), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0030291](http://purl.obolibrary.org/obo/GO_0030291) (protein serine/threonine kinase inhibitor activity), [GO:0034098](http://purl.obolibrary.org/obo/GO_0034098) (VCP-NPL4-UFD1 AAA ATPase complex), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0019789](http://purl.obolibrary.org/obo/GO_0019789) (SUMO transferase activity), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:0060338](http://purl.obolibrary.org/obo/GO_0060338) (regulation of type I interferon-mediated signaling pathway), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0006353](http://purl.obolibrary.org/obo/GO_0006353) (DNA-templated transcription, termination), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:1990599](http://purl.obolibrary.org/obo/GO_1990599) (3' overhang single-stranded DNA endodeoxyribonuclease activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016024](http://purl.obolibrary.org/obo/GO_0016024) (CDP-diacylglycerol biosynthetic process), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), 

**Class expressions from DL-Learner:**

- Thing 53.62%
- [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen) 51.56%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 51.56%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 36.92%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 36.92%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 36.92%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 36.92%


